ATE188123T1 - Rekombinante plasmide enthaltende zusammensetzung und ihre verwendung als impstoff und arzneimittel - Google Patents

Rekombinante plasmide enthaltende zusammensetzung und ihre verwendung als impstoff und arzneimittel

Info

Publication number
ATE188123T1
ATE188123T1 AT95914392T AT95914392T ATE188123T1 AT E188123 T1 ATE188123 T1 AT E188123T1 AT 95914392 T AT95914392 T AT 95914392T AT 95914392 T AT95914392 T AT 95914392T AT E188123 T1 ATE188123 T1 AT E188123T1
Authority
AT
Austria
Prior art keywords
pct
vaccine
composition containing
medicinal product
recombinant plasmids
Prior art date
Application number
AT95914392T
Other languages
English (en)
Inventor
Vincent Ganne
Original Assignee
Seppic Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seppic Sa filed Critical Seppic Sa
Application granted granted Critical
Publication of ATE188123T1 publication Critical patent/ATE188123T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT95914392T 1994-03-22 1995-03-21 Rekombinante plasmide enthaltende zusammensetzung und ihre verwendung als impstoff und arzneimittel ATE188123T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9403361A FR2717694B1 (fr) 1994-03-22 1994-03-22 Une composition comprenant un plasmide recombinant et ses utilisations comme vaccin et médicament.
PCT/FR1995/000345 WO1995025542A1 (fr) 1994-03-22 1995-03-21 Une composition comprenant un plasmide recombinant et ses utilisations comme vaccin et medicament

Publications (1)

Publication Number Publication Date
ATE188123T1 true ATE188123T1 (de) 2000-01-15

Family

ID=9461309

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95914392T ATE188123T1 (de) 1994-03-22 1995-03-21 Rekombinante plasmide enthaltende zusammensetzung und ihre verwendung als impstoff und arzneimittel

Country Status (8)

Country Link
US (1) US5801157A (de)
EP (1) EP0751788B1 (de)
JP (1) JP3436371B2 (de)
AT (1) ATE188123T1 (de)
DE (1) DE69514217T2 (de)
ES (1) ES2144126T3 (de)
FR (1) FR2717694B1 (de)
WO (1) WO1995025542A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707896B1 (fr) * 1993-07-22 1995-09-01 Chemoxal Sa Procédé de traitement d'un article et nouvelle solution aqueuse de peroxyde d'hydrogène.
US6117432A (en) * 1995-04-20 2000-09-12 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
FR2754715B1 (fr) * 1996-10-18 1998-11-13 Seppic Sa Adjuvant, notamment sous forme d'une emulsion contenant un cation metallique trivalent et composition vaccinale le comprenant
DE19637043A1 (de) * 1996-09-12 1998-03-19 Boehringer Mannheim Gmbh Neue Aminoalkoholderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel und Reagenzien
US7097854B2 (en) 1996-09-12 2006-08-29 Medigene Oncology Gmbh Amino alcohol derivatives, process for their production and pharmaceutical preparations and reagents containing these compounds
FR2754182B1 (fr) * 1996-10-07 1998-11-06 Seppic Sa Nouvelles compositions vaccinales comportant comme adjuvant un compose sympathomimetique
GB9626865D0 (en) * 1996-12-24 1997-02-12 Cyanamid Websters Pty Limited Veterinary vaccines
NZ503636A (en) * 1997-10-17 2002-05-31 Fort Dodge Australia Pty Vaccines for the prevention of clostridial diseases of sheep that provide effective immunity for up to a year or more from a single dose
FR2800280B1 (fr) 1999-10-29 2003-09-19 Seppic Sa Nouvelle composition vaccinale et utilisation d'agents tensioactifs comme adjuvants d'immunite
FR2814956B1 (fr) * 2000-10-06 2003-01-24 Seppic Sa Nouvelle composition vaccinale, procede pour sa preparation, utilisation comme composition injectale en medecine humaine ou veterinaire et nouveau procede de conservation
FR2922767B1 (fr) * 2007-10-24 2009-12-18 Seppic Sa Procede de preparation d'une composition vaccinale comprenant au moins un antigene et au moins un adjuvant.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2649012B1 (fr) * 1989-07-03 1991-10-25 Seppic Sa Emulsions multiphasiques injectables
FR2700957B1 (fr) * 1993-01-29 1995-03-03 Seppic Sa Composition de vaccin sous-unitaire recombinant vivant et procédé de préparation.

Also Published As

Publication number Publication date
DE69514217T2 (de) 2000-09-07
WO1995025542A1 (fr) 1995-09-28
JPH09510359A (ja) 1997-10-21
ES2144126T3 (es) 2000-06-01
US5801157A (en) 1998-09-01
EP0751788A1 (de) 1997-01-08
JP3436371B2 (ja) 2003-08-11
DE69514217D1 (de) 2000-02-03
EP0751788B1 (de) 1999-12-29
FR2717694A1 (fr) 1995-09-29
FR2717694B1 (fr) 1996-05-03

Similar Documents

Publication Publication Date Title
ATE188123T1 (de) Rekombinante plasmide enthaltende zusammensetzung und ihre verwendung als impstoff und arzneimittel
BR9809691A (pt) Usos de substâncias de óleo
BRPI9605663B8 (pt) Bis (resorcinil) triazinas.
ATE238038T1 (de) Liposomale formulierungen von mitoxantron
DE69529748D1 (de) Polynukleotide vakzine gegen den papilloma virus
BR9709823B1 (pt) "compostos de amidas de ácido alqueno piridílico e alquino piridílico, métodos de preparação e uso dos mesmos, bem como medicamento".
ATE172636T1 (de) Liposomales verabreichungssystem für biologisch aktive stoffe
DE69326776T2 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
NO303172B1 (no) Biaromatiske propynylforbindelser, anvendelse derav, samt farmas÷ytiske og kosmetiske preparater inneholdende slike forbindelser
HUP0001293A1 (hu) Heterociklusos vegyületek és ezeket tartalmazó gyógyászati készítmények béta-amiloid-peptidek gátlására
CA2215470A1 (fr) Composes biaryles heterocycliques, compositions pharmaceutiques et cosmetiques les contenant et utilisations
MX9501849A (es) Nuevos compuestos biciclicos-aromaticos, composiciones farmaceuticas y cosmeticas que los contienen y sus usos.
AU2002212505A1 (en) Dna expression vectors
ATE297464T1 (de) Pharmazeutische zusammensetzungen zur therapie der herzinsuffizienz
DK0658553T3 (da) Hidtil ukendte polycykliske aromatiske forbindelser, farmaceutiske præparater og kosmetiske sammensætninger indeholdende di
HK1079688A1 (en) Statin product for enhancing cognitive maintenance
HUT77029A (hu) A GAP-protein SH3 doménjéhez kötődni képes peptidek, ezeket kódoló nukleotidszekvenciák és előállításuk és alkalmazásuk
KR970703428A (ko) Hcmv 및 hsv로부터의 융합 당단백질(fusion glycoprotein from hcmv and hsv)
DE69524581D1 (de) Retinal enthaltendes arzneimittel
FR2763592B1 (fr) Nouveaux derives glycosyles des ginkgolides, leur application en tant que medicaments et compositions pharmaceutiques les contenant
NO995838L (no) Nye heteroetynylenforbindelser og farmasoeytiske og kosmetiske preparater inneholdende de samme
DE69333953D1 (de) Promotor des transaldolase-genes von k.lactis und dessen verwendung
ATE245998T1 (de) Somatostatin agoniste zur reduzierung von körpergewicht
ATE256184T1 (de) Promotor des utrophingens
AU2002223402A1 (en) A novel gene therapy agent for haemophilia b and its preparation method

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties